Featured Top Story
If the FDA ultimately agrees, Novavax's option could become the nation's fourth COVID-19 vaccine.
From
To
Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.